Global Carrier Screening Market Report and Forecast 2024-2032

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Carrier Screening Market Overview 
    3.1    Global Carrier Screening Market Historical Value (2017-2023) 
    3.2    Global Carrier Screening Market Forecast Value (2024-2032)
4    Global Carrier Screening Market Landscape*
    4.1    Global Carrier Screening: Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Carrier Screening: Product Landscape
        4.2.1    Analysis by Type
        4.2.2    Analysis by Technology
        4.2.3    Analysis by Medical Condition
5    Global Carrier Screening Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
        5.2.1    Strengths
        5.2.2    Weaknesses
        5.2.3    Opportunities
        5.2.4    Threats
    5.3    Porter’s Five Forces Model
        5.3.1    Bargaining Power of Suppliers
        5.3.2    Bargaining Power of Buyers
        5.3.3    Threat of New Entrants
        5.3.4    Threat of Substitutes
        5.3.5    Degree of Rivalry
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Global Carrier Screening Market Segmentation (2017-2032)
    6.1    Global Carrier Screening Market (2017-2032) by Type
        6.1.1    Market Overview    
        6.1.2    Expanded Carrier Screening            
        6.1.3    Targeted Disease Carrier Screening            
        6.1.4    Customized Panel Testing            
        6.1.5    Predesigned Panel Testing            
    6.2    Global Carrier Screening Market (2017-2032) by Product and Service
        6.2.1    Market Overview    
        6.2.2    Product
        6.2.3    Service
    6.3    Global Carrier Screening Market (2017-2032) by Technology
        6.3.1    Market Overview    
        6.3.2    DNA sequencing            
        6.3.3    Polymerase Chain Reaction (PCR)            
        6.3.4    Microarrays            
        6.3.5    Others        
    6.4    Global Carrier Screening Market (2017-2032) by Medical Condition
        6.4.1    Market Overview    
        6.4.2    Hematologic condition            
        6.4.3    Pulmonary condition            
        6.4.4    Neurological conditions
        6.4.5    Others                        
    6.5    Global Carrier Screening Market (2017-2032) by End User
        6.5.1    Market Overview    
        6.5.2    Hospitals and clinics
        6.5.3    Laboratories
        6.5.4    Fertility clinics                        
        6.5.5    Others
    6.6    Global Carrier Screening Market (2017-2032) by Region
        6.6.1    Market Overview
        6.6.2    North America
        6.6.3    Europe 
        6.6.4    Asia Pacific
        6.6.5    Latin America
        6.6.6    Middle East and Africa
7    North America Carrier Screening Market (2017-2032)
    7.1    North America Carrier Screening Market (2017-2032) by Type
        7.1.1    Market Overview    
        7.1.2    Expanded Carrier Screening            
        7.1.3    Targeted Disease Carrier Screening            
        7.1.4    Customized Panel Testing            
        7.1.5    Predesigned Panel Testing    
    7.2    North America Carrier Screening Market (2017-2032) by Product and Service
        7.2.1    Market Overview    
        7.2.2    Product
        7.2.3    Service
    7.3    North America Carrier Screening Market (2017-2032) by Country
        7.3.1    United States of America
        7.3.2    Canada
8    Europe Carrier Screening Market (2017-2032)
    8.1    Europe Carrier Screening Market (2017-2032) by Type
        8.1.1    Market Overview    
        8.1.2    Expanded Carrier Screening            
        8.1.3    Targeted Disease Carrier Screening            
        8.1.4    Customized Panel Testing            
        8.1.5    Predesigned Panel Testing    
    8.2    Europe Carrier Screening Market (2017-2032) by Product and Service
        8.2.1    Market Overview    
        8.2.2    Product
        8.2.3    Service
    8.3    Europe Carrier Screening Market (2017-2032) by Country
        8.3.1    United Kingdom
        8.3.2    Germany
        8.3.3    France
        8.3.4    Italy
        8.3.5    Others
9    Asia Pacific Carrier Screening Market (2017-2032)
    9.1    Asia Pacific Carrier Screening Market (2017-2032) by Type
        9.1.1    Market Overview    
        9.1.2    Expanded Carrier Screening            
        9.1.3    Targeted Disease Carrier Screening            
        9.1.4    Customized Panel Testing            
        9.1.5    Predesigned Panel Testing    
    9.2    Asia Pacific Carrier Screening Market (2017-2032) by Product and Service
        9.2.1    Market Overview    
        9.2.2    Product
        9.2.3    Service
    9.3    Asia Pacific Carrier Screening Market (2017-2032) by Country
        9.3.1    China
        9.3.2    Japan
        9.3.3    India
        9.3.4    ASEAN
        9.3.5    Australia
        9.3.6    Others
10    Latin America Carrier Screening Market (2017-2032)
    10.1     Latin America Carrier Screening Market (2017-2032) by Type
        10.1.1    Market Overview    
        10.1.2    Expanded Carrier Screening            
        10.1.3    Targeted Disease Carrier Screening            
        10.1.4    Customized Panel Testing            
        10.1.5    Predesigned Panel Testing    
    10.2    Latin America Carrier Screening Market (2017-2032) by Product and Service
        10.2.1    Market Overview    
        10.2.2    Product
        10.2.3    Service
    10.3    Latin America Carrier Screening Market (2017-2032) by Country
        10.3.1    Brazil
        10.3.2    Argentina
        10.3.3    Mexico
        10.3.4    Others
11    Middle East and Africa Carrier Screening Market (2017-2032)
    11.1     Middle East and Africa Carrier Screening Market (2017-2032) by Type
        11.1.1    Market Overview    
        11.1.2    Expanded Carrier Screening            
        11.1.3    Targeted Disease Carrier Screening            
        11.1.4    Customized panel testing            
        11.1.5    predesigned panel testing    
    11.2    Middle East and Africa Carrier Screening Market (2017-2032) by Product and Service
        11.2.1    Market Overview    
        11.2.2    Product
        11.2.3    Service
    11.3     Middle East and Africa Carrier Screening Market (2017-2032) by Country
    11.3.1    Saudi Arabia
    11.3.2    United Arab Emirates
    11.3.3    Nigeria
    11.3.4    South Africa
    11.3.5    Others
12    Regulatory Framework
    12.1     Regulatory Overview
        12.1.1    US FDA
        12.1.2    EU EMA
        12.1.3    INDIA CDSCO
        12.1.4    JAPAN PMDA
        12.1.5     Others
13    Patent Analysis
    13.1     Analysis by Type of Patent
    13.2     Analysis by Publication year
    13.3     Analysis by Issuing Authority
    13.4     Analysis by Patent Age
    13.5     Analysis by CPC Analysis
    13.6     Analysis by Patent Valuation 
    13.7     Analysis by Key Players
14    Grants Analysis
    14.1     Analysis by Year
    14.2     Analysis by Amount Awarded
    14.3     Analysis by Issuing Authority
    14.4     Analysis by Grant Application
    14.5     Analysis by Funding Institute
    14.6     Analysis by Departments
    14.7     Analysis by Recipient Organization 
15    Funding and Investment Analysis
    15.1     Analysis by Funding Instances
    15.2     Analysis by Type of Funding
    15.3     Analysis by Funding Amount
    15.4     Analysis by Leading Players
    15.5     Analysis by Leading Investors
    15.6     Analysis by Geography
16    Partnership and Collaborations Analysis
    16.1     Analysis by Partnership Instances
    16.2     Analysis by Type of Partnership
    16.3     Analysis by Leading Players
    16.4     Analysis by Geography
17    Supplier Landscape
    17.1     Thermo Fisher Scientific 
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications 
    17.2    Invitae Corporation
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Fulgent Genetics
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Otogenetics
        17.4.1     Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5     OPKO Health Inc.
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6     Quest Diagnostics Clinical Laboratories, Inc.
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7     Myriad Genetics, Inc.
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8     Natera, Inc.
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9     Laboratory Corporation of America® Holdings
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Illumina, Inc
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications 
    17.11    MedGenome
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications 
    17.12    CENTOGENE N.V.
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications 
List not exhaustive
18    Global Carrier Screening Market – Distribution Model (Additional Insight)
    18.1     Overview 
    18.2     Potential Distributors 
    18.3     Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)
    20.1     Very Small Companies
    20.2     Small Companies
    20.3     Mid-Sized Companies
    20.4     Large Companies
    20.5     Very Large Companies
21    Payment Methods (Additional Insight)
    21.1     Government Funded
    21.2     Private Insurance
    21.3     Out-of-Pocket

*Additional insights provided are customisable as per client requirements.

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.